Traws Pharma (0T20) Ownership - Who Owns Traws Pharma?
Traws Pharma (0T20) Ownership Overview
- 12.38% Insiders
- 2.84% Mutual Funds
- 33.14% Other Institutional Investors
- 0.99% ETFs
- 50.65% Public Companies and Individual Investors
The ownership structure of Traws Pharma (DE:0T20) stock is a mix of institutional, retail, and individual investors. Approximately 36.97% of the company’s stock is owned by Institutional Investors, 12.38% is owned by Insiders, and 50.65% is owned by Public Companies and Individual Investors.
The ownership structure of Traws Pharma (DE:0T20) stock is a mix of institutional, retail, and individual investors. Approximately 36.97% of the company’s stock is owned by Institutional Investors, 12.38% is owned by Insiders, and 50.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 27, 2026 | Orbimed Advisors Llc | $998,207 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Orbimed Advisors Llc | 1,203,250 | Insider | 7.83% | 8,881,188 |
| Vanguard Index Funds | 330,049 | Institution | 2.15% | 2,436,092 |
| Iain D. Dukes | 171,130 | Insider | 1.11% | 1,263,111 |
| Vanguard | 152,849 | Institution | 0.99% | 1,128,178 |
| Nikolay Savchuk | 150,606 | Insider | 0.98% | 1,111,623 |
| Charles David Pauza | 115,971 | Insider | 0.75% | 855,982 |
| Robert Redfield | 113,919 | Insider | 0.74% | 840,836 |
| Werner Cautreels | 109,222 | Insider | 0.71% | 806,168 |
| Fidelity Concord Street Trust | 106,685 | Institution | 0.69% | 787,442 |
| Parker Charles Nolan | 15,393 | Insider | 0.10% | 113,616 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 330,049 | Institution | 2.15% | 2,436,092 |
| Fidelity Concord Street Trust | 106,685 | Institution | 0.69% | 787,442 |
FAQ
Who Owns Traws Pharma (DE:0T20)?
According to the latest TipRanks data, approximately 36.97% of the company's stock is held by institutional investors, 12.38% is held by insiders, and 50.65% is held by public companies and individual investors.
What percentage of Traws Pharma (DE:0T20) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.97% of Traws Pharma (DE:0T20) stock is held by institutional investors: 2.84% by mutual funds, 0.99% by ETFs and 33.14% by other institutional investors.
What percentage of Traws Pharma (DE:0T20) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.65% of Traws Pharma (DE:0T20) stock is held by public companies and individual investors.
Who owns the most shares of Traws Pharma (DE:0T20)?
Orbimed Advisors Llc owns the most shares of Traws Pharma (DE:0T20).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
